DRKS00023322
Recruiting
Not Applicable
Identification of biomarkers for prognosis of morbidity and mortality of SARS-CoV-2 (COVID-19) patients - COVID-19 biomarker
niversitätsklinikum Münster0 sites250 target enrollmentOctober 19, 2020
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- J12.8
- Sponsor
- niversitätsklinikum Münster
- Enrollment
- 250
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •confirmed COVID\-19 infection
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Cohorts for patients with acute leukemiaNeoplasmsKCT0007129The Catholic University of Korea, Seoul St. Mary's Hospital2,250
Recruiting
Not Applicable
Cohort for biomarkers to predict prognosis and treatment response in acute leukemiaDiseases of the blood and blood -forming organs and certain disorders involving the immune mechanismKCT0002261The Catholic University of Korea, Seoul St. Mary's Hospital1,500
Recruiting
Not Applicable
Identification of predictive biomarkers for treatment outcome in patients with advanced hepatocellular carcinomaDiseases of the digestive systemKCT0002264Yonsei University Health System, Severance Hospital100
Completed
Not Applicable
Elucidation of biomarkers to predict the presence of coronary vulnerable plaqueJPRN-UMIN000009806agasaki University Graduate School of Biomedical Sciences200
Completed
Not Applicable
Prospective study for predictive biomarkers and modified risk scoring model for venous thromboembolism in Japanese patients with unresectable or metastatic cancer.lung cancer, esophageal cancer, gastric cancer, biliary tract cancer, pancreatic cancer, colorectal cancerJPRN-UMIN000026826Clinical Research Center, Saga University Hospital240